Skip to main content
. Author manuscript; available in PMC: 2018 Jan 10.
Published in final edited form as: Int J Pharm. 2016 Oct 31;516(1-2):196–203. doi: 10.1016/j.ijpharm.2016.10.072

Figure 2.

Figure 2

Viability of HaCaT keratinocyte cell line exposed to free VD3 and VD3 encapsulated in TyroSpheres (VD3-Tyr). The % viability was measured by AlamarBlue® assay based on metabolic activity of cells.